A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study.

MLA

Imamura, Fumiaki, et al. “A Combination of Plasma Phospholipid Fatty Acids and Its Association with Incidence of Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.” PLoS Medicine, vol. 14, no. 10, Oct. 2017, p. e1002409. EBSCOhost, https://doi.org/10.1371/journal.pmed.1002409.

APA

Imamura, F., Sharp, S. J., Koulman, A., Schulze, M. B., Kröger, J., Griffin, J. L., Huerta, J. M., Guevara, M., Sluijs, I., Agudo, A., Ardanaz, E., Balkau, B., Boeing, H., Chajes, V., Dahm, C. C., Dow, C., Fagherazzi, G., Feskens, E. J. M., Franks, P. W., … Wareham, N. J. (2017). A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study. PLoS Medicine, 14(10), e1002409. https://doi.org/10.1371/journal.pmed.1002409

Chicago

Imamura, Fumiaki, Stephen J Sharp, Albert Koulman, Matthias B Schulze, Janine Kröger, Julian L Griffin, José M Huerta, et al. 2017. “A Combination of Plasma Phospholipid Fatty Acids and Its Association with Incidence of Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.” PLoS Medicine 14 (10): e1002409. doi:10.1371/journal.pmed.1002409.